New England Biolabs inks deal to supply critical reagents to TriLink BioTechnologies

New England Biolabs, Inc. (NEB®) has strengthened its position as a key supplier to the fast-growing RNA synthesis market by signing an agreement to supply critical reagents to TriLink BioTechnologies, Inc., a leading manufacturer of mRNA and long RNA for research, diagnostic and therapeutic applications. 
Under the terms of the agreement, NEB will manufacture and supply enzymes for in vitro transcription, capping, and poly(A) tailing of RNA.

Commenting on the relationship with NEB, TriLink's President and CEO, Richard Hogrefe, Ph.D., stated, "NEB is a leading supplier of molecular biology enzymes and associated reagents for life science research. This agreement aligns NEB and TriLink in providing the market with the highest quality RNA for projects of all scales."

"We are pleased to formalize our relationship with TriLink, applying our technical and commercial expertise, so that TriLink's services can continue being best-in-class in the RNA synthesis market," said John Pelletier, Director of Customized Solutions and OEM Marketing at NEB. "NEB has built a portfolio of RNA synthesis reagents to address the market's needs for key reagents. By working with innovative companies, such as TriLink, we can help to ensure that these technologies achieve commercial success."



 

Source:

New England Biolabs

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    New England Biolabs. (2019, June 20). New England Biolabs inks deal to supply critical reagents to TriLink BioTechnologies. News-Medical. Retrieved on August 14, 2022 from https://www.news-medical.net/news/20141007/New-England-Biolabs-inks-deal-to-supply-critical-reagents-to-TriLink-BioTechnologies.aspx.

  • MLA

    New England Biolabs. "New England Biolabs inks deal to supply critical reagents to TriLink BioTechnologies". News-Medical. 14 August 2022. <https://www.news-medical.net/news/20141007/New-England-Biolabs-inks-deal-to-supply-critical-reagents-to-TriLink-BioTechnologies.aspx>.

  • Chicago

    New England Biolabs. "New England Biolabs inks deal to supply critical reagents to TriLink BioTechnologies". News-Medical. https://www.news-medical.net/news/20141007/New-England-Biolabs-inks-deal-to-supply-critical-reagents-to-TriLink-BioTechnologies.aspx. (accessed August 14, 2022).

  • Harvard

    New England Biolabs. 2019. New England Biolabs inks deal to supply critical reagents to TriLink BioTechnologies. News-Medical, viewed 14 August 2022, https://www.news-medical.net/news/20141007/New-England-Biolabs-inks-deal-to-supply-critical-reagents-to-TriLink-BioTechnologies.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
New England Biolabs launches new NEBNext Ultra kits at ASHG annual meeting